ISRG - NASDAQ
Intuitive Surgical, Inc.
$407.29
+1.2%Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
At a Glance
Live Snapshotisrg
Total Non-Current Liabilities
Last Annual Value
683.30M
3-Year CAGR
16%
5-Year CAGR
9%
10-Year CAGR
22%
Intuitive Surgical, Inc. Competitors Analysis of Total Non-Current Liabilities
| Company | Total Non-Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Intuitive Surgical, Inc. NASDAQ:ISRG | 683.30M | 21.0% | 8.5% | 19.8% | |
 ResMed Inc. NYSE:RMD | 1.19B | -13.9% | 5.0% | 2.5% | |
 Becton, Dickinson and Company NYSE:BDX | 21.62B | 2.1% | -1.7% | 4.8% | |
 Embecta Corp. NASDAQ:EMBC | 1.48B | -4.2% | 118.5% | N/A | |
439.10M | 16.6% | 2.7% | 2.1% | ||
 Repligen Corporation NASDAQ:RGEN | 707.74M | 0.3% | 24.9% | 21.7% | |
 Stereotaxis, Inc. AMEX:STXS | 11.17M | 18.3% | 6.1% | 29.5% | |
 Baxter International Inc. NYSE:BAX | 10.98B | -6.2% | -11.4% | 9.3% | |
 ICU Medical, Inc. NASDAQ:ICUI | 1.43B | -7.0% | 86.1% | 80.0% | |
 Hologic, Inc. NASDAQ:HOLX | 2.99B | 0.8% | -2.4% | -3.5% | |
 The Cooper Companies, Inc. NASDAQ:COO | 3.04B | -1.0% | 9.5% | 9.4% |
Intuitive Surgical, Inc. Fair Value Envelope
Related Guides
Continue your ISRG research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.